As an LDHA inhibitor, berberine plays a critical role in suppressing LDHA/AMPK-mTOR-mediated pancreatic adenocarcinoma progression (Cheng et al., 2021). The gene discussed is LDHA; the disease is pancreatic adenocarcinoma.